▁Pat 8.3515625
ients 2.064453125
▁with 1.8623046875
▁r 4.67578125
he 0.016998291015625
um 0.0011157989501953125
ato 0.1204833984375
id 0.0007348060607910156
▁ar 0.0171051025390625
th 0.00015866756439208984
rit 9.78708267211914e-05
is 0.0002372264862060547
▁of 7.16015625
▁the 0.5224609375
▁hand 1.376953125
▁experience 4.05859375
▁significant 2.234375
▁challeng 6.47265625
es 0.0002968311309814453
▁in 1.095703125
▁maintain 3.787109375
ing 0.0007491111755371094
▁an 4.875
▁exercise 8.4375
▁and 4.01953125
▁spl 11.34375
int 0.00412750244140625
ing 0.56689453125
▁regime 2.849609375
▁as 3.751953125
▁pres 3.33984375
cribed 0.0017175674438476562
▁by 0.58642578125
▁occup 2.9921875
ational 9.47713851928711e-05
▁ther 0.08135986328125
ap 0.23876953125
ists 0.0259552001953125
. 0.5732421875
▁A 3.501953125
▁natural 8.5546875
istic 1.2373046875
, 2.701171875
▁phenomen 5.53515625
ological 0.1771240234375
▁research 2.919921875
▁approach 1.796875
▁can 6.296875
▁be 1.3818359375
▁used 0.36328125
▁to 0.0616455078125
▁explore 1.3076171875
▁the 0.92919921875
▁lived 0.9697265625
▁experiences 0.8056640625
▁of 0.07830810546875
▁these 1.9189453125
▁patients 0.1788330078125
▁and 2.171875
▁understand 3.876953125
▁the 1.3740234375
▁factors 2.69921875
▁influen 2.548828125
cing 0.00019633769989013672
▁their 0.90771484375
▁ad 1.5732421875
her 0.00998687744140625
ence 0.0038585662841796875
▁to 0.3681640625
▁treatment 2.560546875
. 0.494873046875
▁ 6.1015625
<0x0A> 8.5390625
<0x0A> 0.444580078125
To 4.3125
▁explore 1.5390625
▁these 4.828125
▁questions 4.75390625
, 0.2666015625
▁semi 3.203125
- 0.031585693359375
struct 0.004913330078125
ured 0.0008816719055175781
▁inter 0.1845703125
views 0.0001709461212158203
▁with 2.8203125
▁participants 4.2890625
▁can 8.2890625
▁be 0.2025146484375
▁conducted 0.763671875
▁to 1.6650390625
▁gain 1.6875
▁ins 3.14453125
ights 0.0010662078857421875
▁into 0.0841064453125
▁their 0.418701171875
▁experiences 0.7666015625
▁with 2.853515625
▁the 1.5859375
▁treatment 1.6318359375
▁regime 2.408203125
▁from 6.81640625
▁their 0.436279296875
▁own 1.029296875
▁pers 0.63818359375
pect 0.00019156932830810547
ives 2.4318695068359375e-05
. 0.10888671875
▁Open 4.4375
- 0.323974609375
ended 0.0233306884765625
▁questions 0.2220458984375
▁will 4.99609375
▁allow 2.16796875
▁participants 0.77685546875
▁to 0.006870269775390625
▁describe 1.9296875
▁their 0.2027587890625
▁experiences 0.414794921875
▁in 0.6650390625
▁their 0.316650390625
▁own 0.006618499755859375
▁words 0.03179931640625
. 2.236328125
▁Part 3.31640625
icip 0.0069580078125
ant 2.47265625
▁di 3.23046875
aries 0.06640625
▁kept 5.06640625
▁by 2.58203125
▁the 0.7421875
▁patients 1.435546875
▁over 2.439453125
▁a 0.8896484375
▁period 0.765625
▁of 0.041351318359375
▁time 0.63671875
▁will 1.7685546875
▁provide 1.1513671875
▁a 2.224609375
▁longitud 4.078125
inal 0.0005478858947753906
▁record 2.880859375
▁of 0.0246429443359375
▁their 0.329345703125
▁experiences 0.6787109375
, 2.025390625
▁challeng 4.48828125
es 0.0004360675811767578
, 0.33837890625
▁feelings 7.43359375
, 0.400634765625
▁and 0.169921875
▁re 3.857421875
actions 0.035980224609375
▁to 0.462646484375
▁the 0.517578125
▁treatment 0.2032470703125
. 0.8974609375
▁Research 4.70703125
er 2.09375
▁di 3.21484375
aries 0.03057861328125
▁kept 1.8447265625
▁by 0.71484375
▁the 0.04962158203125
▁interview 6.67578125
ers 0.039276123046875
▁will 0.73583984375
▁capture 3.916015625
▁their 0.65283203125
▁own 2.31640625
▁ref 2.064453125
lections 0.01224517822265625
▁and 0.97900390625
▁ins 2.158203125
ights 0.00035309791564941406
▁gained 1.4873046875
▁through 2.384765625
▁the 0.34521484375
▁process 1.5712890625
. 0.83740234375
▁These 2.83203125
▁multiple 5.078125
▁data 1.3779296875
▁sources 0.1522216796875
▁will 0.60400390625
▁enable 3.333984375
▁tri 3.708984375
ang 0.0003197193145751953
ulation 0.0025997161865234375
▁to 2.1328125
▁verify 2.5546875
▁and 1.4404296875
▁en 4.81640625
rich 0.0039043426513671875
▁the 0.2374267578125
▁find 1.0341796875
ings 6.4373016357421875e-06
. 0.4599609375
<0x0A> 0.78125
<0x0A> 0.0197296142578125
S 4.91015625
ever 1.75
al 0.00817108154296875
▁eth 2.939453125
ical 0.00821685791015625
▁consider 0.34375
ations 4.482269287109375e-05
▁must 0.857421875
▁be 0.0261077880859375
▁addressed 1.2119140625
. 3.162109375
▁Inform 2.31640625
ed 0.0014410018920898438
▁consent 0.01363372802734375
▁must 0.6708984375
▁be 0.0071258544921875
▁obtained 0.051239013671875
▁from 0.11669921875
▁all 0.732421875
▁participants 0.12548828125
▁after 4.99609375
▁explaining 1.7578125
▁the 0.055877685546875
▁research 1.828125
▁object 2.349609375
ives 0.0001652240753173828
▁and 0.50390625
▁what 6.046875
▁their 3.013671875
▁participation 0.484375
▁will 1.1728515625
▁involve 1.3935546875
. 0.07244873046875
▁Part 2.197265625
icip 0.0064849853515625
ants 0.117431640625
▁must 0.76904296875
▁understand 3.845703125
▁that 0.5283203125
▁their 0.9111328125
▁participation 1.716796875
▁is 0.194091796875
▁volunt 0.1666259765625
ary 0.0004329681396484375
▁and 0.261474609375
▁they 0.9677734375
▁can 0.69287109375
▁withdraw 0.193359375
▁at 0.490234375
▁any 0.00011539459228515625
▁time 0.0693359375
. 0.802734375
▁Conf 1.7216796875
ident 0.0005364418029785156
ial 2.3245811462402344e-05
ity 0.00296783447265625
▁must 0.52587890625
▁be 0.048370361328125
▁ens 2.095703125
ured 5.555152893066406e-05
▁by 1.0166015625
▁removing 2.943359375
▁any 1.6337890625
▁ident 0.146728515625
ifying 0.1671142578125
▁information 0.105224609375
▁from 0.41943359375
▁the 0.302978515625
▁data 0.53515625
▁and 1.2646484375
▁secure 4.76171875
ly 0.168701171875
▁storing 0.0938720703125
▁all 2.146484375
▁records 2.283203125
. 0.26171875
▁The 2.361328125
▁potential 3.763671875
▁benefits 2.068359375
▁of 0.478515625
▁gain 8.0546875
ing 0.00021958351135253906
▁valuable 4.19140625
▁ins 0.2890625
ights 9.763240814208984e-05
▁into 0.1737060546875
▁patients 3.0
’ 0.85009765625
▁experiences 0.25146484375
▁and 1.8681640625
▁ident 4.09765625
ifying 0.0004608631134033203
▁strateg 2.228515625
ies 2.8133392333984375e-05
▁to 0.465087890625
▁improve 0.25146484375
▁ad 0.5830078125
her 0.0002238750457763672
ence 0.000820159912109375
▁to 0.7607421875
▁treatment 0.1766357421875
▁must 0.48046875
▁be 0.2369384765625
▁we 0.8134765625
ighed 4.482269287109375e-05
▁against 0.01080322265625
▁any 1.720703125
▁dis 5.13671875
com 0.037933349609375
fort 0.0015859603881835938
▁to 6.7265625
▁participants 0.9306640625
. 1.486328125
▁The 2.6640625
▁research 1.1787109375
▁must 1.6572265625
▁be 0.3125
▁approved 2.26953125
▁by 0.027801513671875
▁an 0.81640625
▁eth 0.9208984375
ics 0.10223388671875
▁review 2.287109375
▁board 0.297119140625
. 1.7705078125
<0x0A> 0.392333984375
<0x0A> 0.01128387451171875
To 3.533203125
▁fully 6.9609375
▁understand 0.43798828125
▁patients 2.103515625
’ 0.1663818359375
▁experiences 0.255126953125
, 0.69482421875
▁a 2.083984375
▁natural 3.681640625
istic 0.0083465576171875
▁inqu 4.16015625
iry 0.0012636184692382812
▁with 3.966796875
▁a 1.1708984375
▁phenomen 0.4033203125
ological 0.00988006591796875
▁emphas 6.9609375
is 0.00042819976806640625
▁on 4.37109375
▁subject 5.34375
ive 0.22900390625
▁experiences 1.1767578125
▁and 2.359375
▁meaning 2.841796875
▁making 1.9560546875
▁is 0.8291015625
▁appropriate 1.533203125
. 0.06964111328125
▁Multiple 6.44140625
▁qual 4.21875
itative 0.00431060791015625
▁data 0.307861328125
▁collection 2.845703125
▁methods 0.324951171875
▁will 1.869140625
▁be 1.2041015625
▁used 0.2410888671875
▁to 0.45947265625
▁gather 2.69140625
▁rich 1.283203125
▁descri 2.76171875
ptions 0.0002601146697998047
▁of 0.3486328125
▁the 1.30078125
▁participants 1.0908203125
’ 0.08087158203125
▁lived 1.8603515625
▁experiences 0.0406494140625
▁of 4.1171875
▁cop 6.18359375
ing 0.0002779960632324219
▁with 0.030181884765625
▁the 1.08203125
▁treatment 0.25634765625
▁regime 0.541015625
▁for 4.18359375
▁r 0.307861328125
he 6.139278411865234e-05
um 8.749961853027344e-05
ato 0.0005993843078613281
id 4.410743713378906e-06
▁ar 0.0127410888671875
th 2.4437904357910156e-05
rit 0.00015914440155029297
is 0.0004534721374511719
▁in 2.623046875
▁their 0.66943359375
▁own 0.424560546875
▁words 0.0496826171875
. 0.08221435546875
▁By 4.81640625
▁expl 2.7734375
oring 9.894371032714844e-05
▁both 5.484375
▁positive 3.27734375
▁experiences 5.46875
▁that 5.18359375
▁encou 3.552734375
rage 4.744529724121094e-05
▁ad 0.2164306640625
her 0.0003790855407714844
ence 0.0012502670288085938
▁as 2.458984375
▁well 0.0004086494445800781
▁as 0.0018033981323242188
▁challeng 1.0595703125
es 0.08514404296875
▁that 0.5771484375
▁disc 2.228515625
ou 5.6743621826171875e-05
rage 0.0034847259521484375
▁ad 0.31982421875
her 0.0001901388168334961
ence 0.0005049705505371094
, 0.1107177734375
▁the 1.3017578125
▁research 0.65966796875
▁a 3.185546875
ims 2.300739288330078e-05
▁to 0.0032024383544921875
▁identify 1.25
▁factors 2.150390625
▁influen 1.5361328125
cing 0.00011360645294189453
▁patients 1.6767578125
’ 0.0787353515625
▁comp 5.0078125
liance 0.0006990432739257812
▁with 0.5849609375
▁treatment 1.0078125
▁to 3.95703125
▁inform 1.619140625
▁improved 5.04296875
▁practice 3.720703125
. 0.54638671875
